- Argentina
- Finland
- Japan
- Senegal
- France
- Korea
- Slovakia
- Australia
- Germany
- Malaysia/Singapore
- South Africa
- Austria
- Greece
- Mexico
- Spain
- Belgium
- Hong Kong
- Netherlands
- Sweden
- Brazil
- Hungary
- New Zealand
- Switzerland
- Canada
- India
- Norway
- Taiwan
- China
- Indonesia
- Pakistan
- Thailand
- Colombia
- Ireland
- Philippines
- Turkey
- Czech Republic
- Israel
- Poland
- United Kingdom
- Denmark
- Italy
- Portugal
- Venezuela
Policy—Criteria For Selection Of Compensation Committee Consultant
The Compensation Committee established the following criteria used to select a consultant to the Compensation Committee.
- Degree of independence
- Financial independence—measured by dollar volume of other business conducted with Pfizer
- Independent thinking—subjectively assessed by their known work as well as information gathered in the screening interviews
- Familiarity with the business environment
- Knowledge of the pharmaceutical industry
- Specific knowledge of Pfizer Inc, its senior management, and Board of Directors
- Broad knowledge of general industry current practices and emerging trends
- Public relations
- Particular strengths and/or distinguishing characteristics including, but not limited to:
- Creative thinking
- Strong sense of corporate governance
- Special areas of expertise
- Ability to establish rapport or dynamic presence with groups
- References from current clients where the consultant acts in an advisory role similar to the role desired by the Pfizer Compensation Committee
- Potential issues
- Conflict of interest with other clients
- Degree of availability/accessibility